drugset / Trial / NCT00708942

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

NCT00708942 ↗

Phase 2 Terminated 83 enrolled Photocure
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study will examine the effect of HAL vs placebo photodynamic therapy of low-grade cervical precancerous lesions (dysplasia) in women.

Timeline

Start
2009-01
Primary completion
2012-01
Completion
2012-01

Outcome

Outcome not reported

Stopped (Enrollment): “Slow recruitment, study stopped with only 13 of 70 patients included in second part of the study”

Drugs

EvaluationDrugModalityDoseRoute
Comparator hexaminolevulinate Small molecule 100 mg —